Df Dent & Co Has Trimmed Position in Roper Technologies (ROP) by $12.53 Million; As Portola Pharmaceuticals Com (PTLA) Share Price Rose, Fernwood Investment Management Has Cut Its Holding

February 22, 2018 - By Linda Rogers

Df Dent & Co Inc decreased its stake in Roper Technologies Inc (ROP) by 7.1% based on its latest 2017Q3 regulatory filing with the SEC. Df Dent & Co Inc sold 51,551 shares as the company’s stock rose 6.97% with the market. The institutional investor held 674,931 shares of the capital goods company at the end of 2017Q3, valued at $164.28M, down from 726,482 at the end of the previous reported quarter. Df Dent & Co Inc who had been investing in Roper Technologies Inc for a number of months, seems to be less bullish one the $28.50 billion market cap company. The stock increased 0.61% or $1.69 during the last trading session, reaching $278.43. About 531,567 shares traded or 15.41% up from the average. Roper Technologies, Inc. (NYSE:ROP) has risen 23.10% since February 22, 2017 and is uptrending. It has outperformed by 6.40% the S&P500.

Fernwood Investment Management Llc decreased its stake in Portola Pharmaceuticals Inc Com (PTLA) by 3.89% based on its latest 2017Q3 regulatory filing with the SEC. Fernwood Investment Management Llc sold 9,300 shares as the company’s stock rose 22.73% with the market. The institutional investor held 229,577 shares of the health care company at the end of 2017Q3, valued at $12.40 million, down from 238,877 at the end of the previous reported quarter. Fernwood Investment Management Llc who had been investing in Portola Pharmaceuticals Inc Com for a number of months, seems to be less bullish one the $2.93B market cap company. The stock decreased 6.86% or $3.31 during the last trading session, reaching $44.91. About 2.76M shares traded or 187.45% up from the average. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has risen 51.17% since February 22, 2017 and is uptrending. It has outperformed by 34.47% the S&P500.

Investors sentiment increased to 2.16 in Q3 2017. Its up 0.85, from 1.31 in 2017Q2. It is positive, as 20 investors sold PTLA shares while 37 reduced holdings. 38 funds opened positions while 85 raised stakes. 56.33 million shares or 15.80% more from 48.64 million shares in 2017Q2 were reported. Citigroup owns 60,014 shares. Creative Planning has invested 0.01% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Fred Alger Management reported 0.18% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Hightower Advisors Limited Liability Corporation has 4,045 shares. Capstone Advisors Ltd Liability owns 6,548 shares. Castleark Management Limited Liability Company holds 0.17% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) or 99,791 shares. State Bank Of America De invested 0% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Raymond James & Assoc holds 0% or 4,570 shares in its portfolio. Jane Street Group Ltd holds 0% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) or 26,571 shares. Bluemountain Cap Mgmt Lc reported 0.04% stake. Credit Agricole S A owns 37,500 shares. State Of Wisconsin Invest Board accumulated 50,667 shares or 0.01% of the stock. Stifel Fin accumulated 4,964 shares. Metropolitan Life Ins Company New York accumulated 0.01% or 36,939 shares. Fisher Asset Mgmt Limited Co holds 0% of its portfolio in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) for 61,893 shares.

Since December 15, 2017, it had 0 insider purchases, and 1 sale for $563,950 activity.

Among 6 analysts covering Portola Pharmaceuticals (NASDAQ:PTLA), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Portola Pharmaceuticals had 34 analyst reports since August 5, 2015 according to SRatingsIntel. The company was maintained on Monday, June 26 by Citigroup. The rating was downgraded by Citigroup to “Neutral” on Friday, August 19. The company was maintained on Thursday, August 10 by Oppenheimer. Oppenheimer maintained it with “Buy” rating and $8000 target in Friday, August 4 report. Credit Suisse maintained the stock with “Outperform” rating in Wednesday, February 21 report. Goldman Sachs downgraded Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) on Monday, March 28 to “Neutral” rating. The firm earned “Buy” rating on Wednesday, August 5 by Cowen & Co. As per Tuesday, December 19, the company rating was maintained by Oppenheimer. The rating was upgraded by Citigroup on Tuesday, January 3 to “Buy”. The rating was initiated by Goldman Sachs with “Buy” on Friday, December 18.

Analysts await Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) to report earnings on February, 28 after the close. They expect $-1.52 EPS, down 60.00% or $0.57 from last year’s $-0.95 per share. After $-1.41 actual EPS reported by Portola Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 7.80% negative EPS growth.

Analysts await Roper Technologies, Inc. (NYSE:ROP) to report earnings on April, 27. They expect $2.49 earnings per share, up 18.01% or $0.38 from last year’s $2.11 per share. ROP’s profit will be $254.88M for 27.95 P/E if the $2.49 EPS becomes a reality. After $2.70 actual earnings per share reported by Roper Technologies, Inc. for the previous quarter, Wall Street now forecasts -7.78% negative EPS growth.

Since September 12, 2017, it had 0 insider purchases, and 7 sales for $104.16 million activity. 4,000 shares were sold by KNOWLING ROBERT E JR, worth $1.04 million on Tuesday, October 31. $1.23M worth of Roper Technologies, Inc. (NYSE:ROP) was sold by Conley Jason. $118,520 worth of Roper Technologies, Inc. (NYSE:ROP) was sold by WRIGHT CHRISTOPHER. Thatcher Laura G had sold 1,000 shares worth $235,473.

Df Dent & Co Inc, which manages about $3.85B US Long portfolio, upped its stake in Lithia Motors Inc Cl A (NYSE:LAD) by 2,714 shares to 9,765 shares, valued at $1.18 million in 2017Q3, according to the filing. It also increased its holding in Heico Corp New Cl A (NYSE:HEI.A) by 8,489 shares in the quarter, for a total of 22,056 shares, and has risen its stake in Watsco Inc Com (NYSE:WSO).

Among 13 analysts covering Roper Industries Inc. (NYSE:ROP), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Roper Industries Inc. had 52 analyst reports since July 29, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, April 12 report. On Tuesday, February 2 the stock rating was maintained by RBC Capital Markets with “Outperform”. On Wednesday, October 11 the stock rating was maintained by RBC Capital Markets with “Buy”. The firm has “Buy” rating by Stifel Nicolaus given on Wednesday, November 25. The stock of Roper Technologies, Inc. (NYSE:ROP) has “Hold” rating given on Wednesday, October 19 by Argus Research. Oppenheimer maintained the shares of ROP in report on Monday, July 31 with “Buy” rating. The firm has “Buy” rating given on Friday, July 7 by Stifel Nicolaus. The company was maintained on Sunday, February 4 by Robert W. Baird. RBC Capital Markets maintained Roper Technologies, Inc. (NYSE:ROP) on Thursday, September 28 with “Buy” rating. The company was maintained on Monday, May 1 by RBC Capital Markets.

Investors sentiment increased to 1.28 in Q3 2017. Its up 0.34, from 0.94 in 2017Q2. It increased, as 19 investors sold ROP shares while 170 reduced holdings. 58 funds opened positions while 184 raised stakes. 98.93 million shares or 4.07% more from 95.07 million shares in 2017Q2 were reported. Hudson Bay Cap Management LP reported 5,000 shares or 0.03% of all its holdings. Gulf Intll Savings Bank (Uk) Ltd has invested 0.1% in Roper Technologies, Inc. (NYSE:ROP). Thrivent Fincl For Lutherans, Minnesota-based fund reported 100,051 shares. Crawford Inv Counsel stated it has 0.01% of its portfolio in Roper Technologies, Inc. (NYSE:ROP). Flossbach Von Storch Ag accumulated 39,050 shares. Commonwealth Equity Serv has invested 0.01% in Roper Technologies, Inc. (NYSE:ROP). 1,959 were accumulated by Livforsakringsbolaget Skandia Omsesidigt. Clarkston Capital Partners Limited Liability Co has invested 0.07% in Roper Technologies, Inc. (NYSE:ROP). Bessemer Grp Inc Incorporated invested in 2,885 shares or 0% of the stock. Argent Trust holds 0.1% or 1,492 shares. Lpl Fincl Ltd Llc has invested 0% in Roper Technologies, Inc. (NYSE:ROP). Raymond James & Associates stated it has 222,878 shares. Tci Wealth invested in 103 shares or 0.01% of the stock. Btim reported 10,661 shares. Intact Mgmt Inc owns 0.01% invested in Roper Technologies, Inc. (NYSE:ROP) for 1,400 shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>